Inventaire - your friends and communities are your best library

A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study.

author

Marco Agostino Deriu

Francesco Gentile

Khaled Barakat

Andrea Danani

Jack Tuszyński

1956 -

published in: Pharmaceuticals

date of publication: 2018-02-16

main subject: toll-like receptor, (S)-(−)-colchicine

Cites articles 42

Date

Title

Authors

2017-08-10

Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity

Alexis Courbet, Martine Pugniere, Sonia Khier
2017-05-31

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
2017-01-01

Novel Colchicine Derivatives and their Anti-cancer Activity

Jack Tuszyński
2016-10-15

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site
2016-10-11

Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.

Susumu Uchiyama
2015-05-08

Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations

Francesco Gentile, Marco Agostino Deriu, Andrea Danani, Jack Tuszyński
2014-09-25

Toll-like receptor signaling pathways.
2014

Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use
2014-01-23

Discovery and saturation analysis of cancer genes across 21 tumour types

Eric Lander, Gad Getz, Petar Stojanov, Matthew Meyerson, Craig H Mermel, Stacey Gabriel, Levi A Garraway, Todd Golub
2014-03-20

Homology and molecular dynamics models of toll-like receptor 7 protein and its dimerization

Jack Tuszyński
2013-08-20

Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
2013-01-01

TLR7 inhibition: A novel strategy for pancreatic cancer treatment?

Tatjana Eigenbrod, Alexander Dalpke
2013-03-29

Cancer genome landscapes

Bert Vogelstein, Kenneth W Kinzler, Victor Velculescu, Luis Alberto Diaz Jr, Nickolas Papadopoulos, Shibin Zhou
2013-03-22

Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands
2013-03-08

TLR agonists: our best frenemy in cancer immunotherapy
2012-08-16

MMPBSA.py: An Efficient Program for End-State Free Energy Calculations

Nadine Homeyer, Adrian Roitberg
2012-12-04

Resiquimod, a topical drug for viral skin lesions and skin cancer

Lars E French, Eggert Stockfleth
2012-11-01

Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans

Atsuo Ochi, Christopher S Graffeo, Constantinos P Zambirinis, Rocky Barilla, Mohsin Jamal, Stephanie H. Greco, Nina C Fallon, Adeel Ur Rehman, Cristina H Hajdu, Justin R Henning, Usama Bin Saeed, Melvin O Ego-Osuala
2012

Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation
2012-07-20

An overview of tubulin inhibitors that interact with the colchicine binding site
2012-06-28

New developments in Toll-like receptor targeted therapeutics

Luke A. J. O'Neill
2012-03-01

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
2012-02-22

Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model
2012-03-28

Systematic identification of genomic markers of drug sensitivity in cancer cells

Michael Stratton, P. Andrew Futreal, Graham R. Bignell, Julio Saez-Rodriguez, Cyril H. Benes
2012-04-27

Negative regulation of the type I interferon signaling pathway by synthetic Toll-like receptor 7 ligands
2010-03-30

A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains

Robert W. Stark
2009-08-01

Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains

Robert W. Stark
2009-11-01

CL097, a TLR7/8 ligand, inhibits TLR-4--dependent activation of IRAK-M and BCL-3 expression

Barbara Wessner, Andreas Spittler, Michael Bergmann
2008-08-13

The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy

Zwi Berneman
2008-01-01

TLR7 and TLR8 as targets in cancer therapy
2008-07-01

The generalized Born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area
2006-02-01

New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies

Gabriela Chiosis, Giuseppe La Regina, Romano Silvestri, Andrea Brancale

Article - wd:Q49805153

Welcome to Inventaire

the library of your friends and communities

learn more